The 50th Annual Meeting of the European Society for Blood and Marrow Transplantation: Patient Advocacy – Poster Session (P808-P815) - Summary - MDSpire

The 50th Annual Meeting of the European Society for Blood and Marrow Transplantation: Patient Advocacy – Poster Session (P808-P815)

  • October 8, 2024

  • 0 min

Share

Objective:

Add significance of aHSCT in lymphoma and CLL context.

Key Findings:
  • Add statistical significance for all findings.
Interpretation:

Elaborate on implications of regional disparities.

Limitations:
  • Expand on potential biases or confounding factors.
Conclusion:

Reiterate importance of ongoing research.

Original Source(s)

The 50th Annual Meeting of the European Society for Blood and Marrow Transplantation: Patient Advocacy – Poster Session (P808-P815)

  • October 8, 2024

Related Content

HDAC7 controls anti-viral and anti-tumor immunity by CD8+ T cells

Metabolic Diversity in Tumors Assessed by 18F-FDG PET/CT as a Prognostic Indicator in Diffuse Large B-Cell Lymphoma

Optimisation of patient-reported outcome measurement for haematological cancer patients receiving novel immunotherapies: perspectives of multi-stakeholders